Baptiste Louveau
Overview
Explore the profile of Baptiste Louveau including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
114
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Louveau B, Reger De Moura C, Jouenne F, Sadoux A, Allayous C, Meda L, et al.
Melanoma Res
. 2023 Dec;
34(2):186-192.
PMID: 38141200
Upregulation of phosphodiesterase type 4 (PDE4) has been associated with worse prognosis in several cancers. In melanomas harboring NRAS mutations, PDE4 upregulation has been shown to trigger a switch in...
12.
Ranjbaryan M, Calvani J, Louveau B, Cuccuini W, Battesti G, Bozonnat A, et al.
Eur J Dermatol
. 2023 Oct;
33(4):439-440.
PMID: 37823502
No abstract available.
13.
Cohen E, Bozonnat A, Battistella M, Calvani J, Vignon-Pennamen M, Rivet J, et al.
J Eur Acad Dermatol Venereol
. 2023 Aug;
38(1):e32-e34.
PMID: 37561935
No abstract available.
14.
Delyon J, Vallet A, Bernard-Cacciarella M, Kuzniak I, Reger De Moura C, Louveau B, et al.
Cancers (Basel)
. 2023 Jun;
15(11).
PMID: 37296851
Because BRAF-mutated melanomas are addicted to the Mitogen Activated Protein Kinase (MAPK) pathway they show a high response rate to BRAF and MEK inhibitors. However, the clinical responses to these...
15.
Bogiatzi S, Estenaga A, Louveau B, Osio A, Deschamps L, Mourah S, et al.
J Cutan Pathol
. 2023 Feb;
50(10):897-902.
PMID: 36790018
Microsecretory adenocarcinoma (MSA) is a newly described salivary gland tumor harboring a characteristic balanced chromosomal translocation resulting in MEF2C::SS18 gene fusion. Six primary cutaneous MSA cases have been recently described....
16.
Lazaridou I, Calvani J, Annabi E, Moins-Teisserenc H, Ta V, Rivet J, et al.
J Eur Acad Dermatol Venereol
. 2023 Jan;
37(6):e715-e717.
PMID: 36645855
No abstract available.
17.
Moghadam P, Herms F, Baroudjian B, Tetu P, Delyon J, Jouenne F, et al.
J Eur Acad Dermatol Venereol
. 2022 Aug;
37(1):e119-e121.
PMID: 35993817
No abstract available.
18.
Maillard M, Louveau B, Vilquin P, Goldwirt L, Thomas F, Mourah S
Therapie
. 2021 Dec;
77(2):171-183.
PMID: 34922740
The discovery of molecular alterations involved in oncogenesis is evolving rapidly and has led to the development of new innovative targeted therapies in oncology. High-throughput sequencing techniques help to identify...
19.
de Masson A, Darbord D, Dobos G, Boisson M, Roelens M, Ram-Wolff C, et al.
Blood
. 2021 Dec;
139(12):1820-1832.
PMID: 34905599
Cutaneous T-cell lymphomas (CTCLs) are rare malignancies involving primarily the skin. Responses to treatment are usually short-lived in advanced CTCL. The determinants of long-term CTCL control are unclear. Mogamulizumab, an...
20.
Oules B, Mourah S, Baroudjian B, Jouenne F, Delyon J, Louveau B, et al.
Virchows Arch
. 2021 May;
480(2):475-480.
PMID: 34013383
Wnt/β-catenin signaling plays crucial roles in melanocyte biology and may be implicated in melanoma progression. In this study, we retrospectively examined a real-life cohort of melanomas mutated for β-catenin (CTNNB1),...